207_Combined course Presentations

Take Home Message for Oligometastatic NSCLC

 A combination of chemo or immunotherapy + local therapies could probably improve patients outcome in this setting, at least in selected subgroups

 Phase III trials are warranted to confirm the effectiveness of a multimodality approach in this setting.

 In the meantime…

Unity Makes Strength…!